• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Status of Measles Elimination in Eleven Countries with High Routine Immunisation Coverage in The WHO African Region.世卫组织非洲区域十一个常规免疫覆盖率高的国家的麻疹消除状况
J Immunol Sci. 2018 Jul 28;Suppl:140-144.
2
Tracking Measles and Rubella Elimination Progress-World Health Organization African Region, 2022-2023.追踪麻疹和风疹消除进展——世界卫生组织非洲区域,2022 - 2023年
Vaccines (Basel). 2024 Aug 22;12(8):949. doi: 10.3390/vaccines12080949.
3
Progress towards measles elimination in Eritrea: 2003 - 2018.厄立特里亚在消除麻疹方面取得的进展:2003 - 2018年
Pan Afr Med J. 2020 Jan 3;35(Suppl 1):7. doi: 10.11604/pamj.supp.2020.35.1.19126. eCollection 2020.
4
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.14 个高负担国家常规麻疹疫苗接种和补充免疫活动的健康影响:动态麻疹免疫计算引擎(DynaMICE)建模研究。
Lancet Glob Health. 2023 Aug;11(8):e1194-e1204. doi: 10.1016/S2214-109X(23)00220-6.
5
Progress of Measles and Rubella Surveillance in the Context of Measles Elimination in the WHO Eastern Mediterranean Region, 2019-2022.2019 - 2022年世界卫生组织东地中海区域在消除麻疹背景下的麻疹和风疹监测进展
Vaccines (Basel). 2024 Nov 29;12(12):1349. doi: 10.3390/vaccines12121349.
6
A scorecard of progress towards measles elimination in 15 west African countries, 2001-19: a retrospective, multicountry analysis of national immunisation coverage and surveillance data.15 个西非国家消除麻疹进展记分卡:2001-2019 年:对国家免疫覆盖和监测数据的回顾性多国分析。
Lancet Glob Health. 2021 Mar;9(3):e280-e290. doi: 10.1016/S2214-109X(20)30481-2.
7
Progress Toward Measles Elimination - South-East Asia Region, 2003-2020.迈向消除麻疹的进展 - 东南亚区域,2003-2020 年。
MMWR Morb Mortal Wkly Rep. 2022 Aug 19;71(33):1042-1046. doi: 10.15585/mmwr.mm7133a2.
8
Progress Toward Measles Elimination - African Region, 2013-2016.2013 - 2016年非洲区域在消除麻疹方面取得的进展
MMWR Morb Mortal Wkly Rep. 2017 May 5;66(17):436-443. doi: 10.15585/mmwr.mm6617a2.
9
Introduction of the Second Dose of Measles Containing Vaccine in the Childhood Vaccination Programs Within the WHO Africa Region - Lessons Learnt.在世卫组织非洲区域的儿童疫苗接种计划中引入含麻疹疫苗的第二剂次——经验教训
J Immunol Sci. 2018 Jul 28;Suppl:113-121.
10
Progress with the Second Dose Measles Vaccine Introduction and Coverage in the WHO African Region.世界卫生组织非洲区域引入第二剂麻疹疫苗及提高疫苗覆盖率的进展情况。
Vaccines (Basel). 2024 Sep 18;12(9):1069. doi: 10.3390/vaccines12091069.

引用本文的文献

1
Trends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022.坦桑尼亚麻疹趋势:基于病例的监测数据 2018-2022 年 5 年回顾。
Int J Infect Dis. 2024 Feb;139:176-182. doi: 10.1016/j.ijid.2023.12.007. Epub 2023 Dec 18.
2
Measles outbreak in Zimbabwe: An urgent rising concern.津巴布韦麻疹疫情:一个亟待关注的问题。
Ann Med Surg (Lond). 2022 Sep 10;82:104613. doi: 10.1016/j.amsu.2022.104613. eCollection 2022 Oct.
3
Measles incidence in South Africa: a six-year review, 2015-2020.南非麻疹发病率:六年回顾,2015-2020 年。
BMC Public Health. 2022 Aug 30;22(1):1647. doi: 10.1186/s12889-022-14069-w.
4
Evaluation of the measles case-based surveillance system in Kwekwe city, 2017-2020: a descriptive cross-sectional study.2017-2020 年奎奎市基于病例的麻疹监测系统评价:描述性横断面研究。
Pan Afr Med J. 2022 Jun 10;42:113. doi: 10.11604/pamj.2022.42.113.31373. eCollection 2022.
5
Epidemiology of measles cases, vaccine effectiveness, and performance towards measles elimination in The Gambia.冈比亚麻疹病例的流行病学、疫苗效力以及消除麻疹方面的表现。
PLoS One. 2021 Oct 21;16(10):e0258961. doi: 10.1371/journal.pone.0258961. eCollection 2021.
6
Full immunization coverage and its associated factors among children aged 12-23 months in Ethiopia: further analysis from the 2016 Ethiopia demographic and health survey.埃塞俄比亚 12-23 个月龄儿童的完全免疫覆盖率及其相关因素:来自 2016 年埃塞俄比亚人口与健康调查的进一步分析。
BMC Public Health. 2019 Jul 30;19(1):1019. doi: 10.1186/s12889-019-7356-2.

本文引用的文献

1
Progress Toward Measles Elimination - Nepal, 2007-2014.向消除麻疹迈进——尼泊尔,2007-2014 年。
MMWR Morb Mortal Wkly Rep. 2016 Mar 4;65(8):206-10. doi: 10.15585/mmwr.mm6508a3.
2
Verification of measles elimination in Australia: Application of World Health Organization regional guidelines.澳大利亚消除麻疹的验证:世界卫生组织区域准则的应用。
J Epidemiol Glob Health. 2016 Sep;6(3):197-209. doi: 10.1016/j.jegh.2015.12.004. Epub 2016 Jan 27.
3
A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008.2009 - 2014年与2001 - 2008年美国消除麻疹后流行病学比较
J Pediatric Infect Dis Soc. 2017 Mar 1;6(1):40-48. doi: 10.1093/jpids/piv080.
4
Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.刚果民主共和国麻疹疫情卷土重来的先前原因。
Pan Afr Med J. 2015 May 15;21:30. doi: 10.11604/pamj.2015.21.30.6335. eCollection 2015.
5
Global progress towards regional measles elimination, worldwide, 2000–2013.2000 - 2013年全球在区域消除麻疹方面取得的进展。
Wkly Epidemiol Rec. 2014 Nov 14;89(46):509-16.
6
Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance data.监测中国消除麻疹的进展:麻疹监测数据分析
Bull World Health Organ. 2014 May 1;92(5):340-7. doi: 10.2471/BLT.13.130195. Epub 2014 Feb 5.
7
Measles resurgence in southern Africa: challenges to measles elimination.南部非洲麻疹卷土重来:消除麻疹面临的挑战。
Vaccine. 2014 Apr 1;32(16):1798-807. doi: 10.1016/j.vaccine.2014.01.089. Epub 2014 Feb 13.
8
Framework for verifying elimination of measles and rubella.麻疹和风疹消除验证框架。
Wkly Epidemiol Rec. 2013 Mar 1;88(9):89-99.
9
Successful control and impending elimination of measles in the Islamic Republic of Iran.伊朗伊斯兰共和国成功控制并即将消除麻疹。
J Infect Dis. 2011 Jul;204 Suppl 1:S305-11. doi: 10.1093/infdis/jir076.
10
Measles mortality reduction and pre-elimination in the African region, 2001-2009.2001-2009 年非洲区域降低麻疹死亡率和消除麻疹前阶段的情况。
J Infect Dis. 2011 Jul;204 Suppl 1:S198-204. doi: 10.1093/infdis/jir116.

世卫组织非洲区域十一个常规免疫覆盖率高的国家的麻疹消除状况

Status of Measles Elimination in Eleven Countries with High Routine Immunisation Coverage in The WHO African Region.

作者信息

Masresha Balcha, Luce Richard, Shibeshi Messeret, Katsande Reggis, Fall Amadou, Okeibunor Joseph, Weldegebriel Goitom, Mihigo Richard

机构信息

WHO Regional Office for Africa, Brazzaville, Congo.

WHO Inter-country Support Team for Central Africa, Libreville, Gabon.

出版信息

J Immunol Sci. 2018 Jul 28;Suppl:140-144.

PMID:30766973
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6372061/
Abstract

BACKGROUND

Measles elimination is defined as the absence of endemic measles virus transmission in a defined geographic area for at least 12 months in the presence of a well-performing surveillance system. The WHO framework for verification of measles elimination indicates that the achievement of measles and/or rubella elimination should be verified for individual countries.

OBJECTIVE

We identified 11 high performing countries based on their first dose measles vaccination coverage, and looked at their performance across the various programmatic parameters, to see if they are ready to undertake the verification of measles elimination.

METHODS

We identified 11 countries with >90% measles first dose coverage for the most recent 5 years according to the WHO UNICEF estimates of national immunisation coverage. We analysed vaccination coverage and surveillance performance in these countries.

RESULTS

Algeria, Botswana, Gambia, Mauritius, Rwanda, Seychelles have maintained measles first dose (MCV1) coverage of 95% or more since 2011. In 2015, only Algeria, Cape Verde and Seychelles had coverage of 95% or more for the second dose of measles vaccine (MCV2). Of the 22 supplemental immunisation activities (SIAs) among the 11 countries, only 6 had administrative coverage of less than 95%. Only Rwanda and Lesotho attained the case-based surveillance performance targets in all the five years.

CONCLUSION

Despite their high routine first dose measles immunisation coverage, all of the 11 countries have some program gaps indicating that they do not meet all the criteria to undergo verification of elimination at this point. It is recommended for these countries to set up national verification committees as per the WHO framework for verification of measles elimination, in order to initiate the documentation and monitoring of progress, and to address programmatic gaps in the coming years.

摘要

背景

消除麻疹的定义是在运转良好的监测系统存在的情况下,在特定地理区域内至少12个月没有地方性麻疹病毒传播。世卫组织麻疹消除验证框架表明,应针对各个国家对麻疹和/或风疹消除的实现情况进行验证。

目的

我们根据11个国家的首剂麻疹疫苗接种覆盖率确定了这些表现出色的国家,并研究了它们在各项规划参数方面的表现,以确定它们是否准备好进行麻疹消除验证。

方法

根据世卫组织/联合国儿童基金会对国家免疫覆盖率的估计,我们确定了11个在最近5年麻疹首剂覆盖率超过90%的国家。我们分析了这些国家的疫苗接种覆盖率和监测表现。

结果

自2011年以来,阿尔及利亚、博茨瓦纳、冈比亚、毛里求斯、卢旺达、塞舌尔的麻疹首剂(MCV1)覆盖率保持在95%或更高。2015年,只有阿尔及利亚、佛得角和塞舌尔的麻疹疫苗第二剂(MCV2)覆盖率达到95%或更高。在这11个国家的22次补充免疫活动(SIAs)中,只有6次行政覆盖率低于95%。只有卢旺达和莱索托在所有五年中都达到了基于病例的监测表现目标。

结论

尽管这11个国家的首剂麻疹常规免疫覆盖率很高,但所有国家都存在一些规划差距,这表明它们目前尚未满足进行消除验证的所有标准。建议这些国家按照世卫组织麻疹消除验证框架设立国家验证委员会,以便启动进展情况的记录和监测,并在未来几年解决规划差距问题。